Clal Biotechnology Industries
Venture capitalTel Aviv · Seed–Late Stage · 9 people tracked
Find your way into Clal Biotechnology Industries
988 people in our graph share verified history with the Clal Biotechnology Industries team — schools, employers, funds. One of them is your warm intro.
Investment thesis
CBI concentrates on the life sciences sector, backing companies that develop proprietary solutions addressing unmet medical needs with significant market potential. It builds and oversees a global portfolio of innovative healthcare ventures, aiming to advance treatments worldwide. As a publicly listed investment firm, CBI identifies and nurtures groundbreaking science-driven businesses from an early stage through their development.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & curated & public directoriesWhat they invest in
from 10 of 10 portfolio companiesBiotech ×8Healthtech ×7Medical Devices ×5Digital Health ×3AI & Machine Learning ×2Hardware ×2
HQs:United States×3Israel×2
Investments · 10 tracked
founders shown can be your intro pathMediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds.
BiotechHealthtechMedical DevicesYavne
Boaz Gur-Lavie(Chief Financial Officer)Sharon Malka(Director)Ety Klinger(Executive Officer, Director)inTzvi Palash(Executive Officer)Assaf Segal(Director)Sharon Kochan(Director)
PartnerAvi Fischer· solo GP
Co-investorsDeep InsightGandyr InvestmentsIsrael Biotech FundNew Era Capital Partners
BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.
BiotechDigital HealthHealthtechMedical DevicesJerusalem, IL
Amnon Peled(CEO/CSO)Simone Cabilly(Chief Scientist)
PartnerAvi Fischer· solo GP
Colospan develops the CG-100, an internal bypass medical device for colorectal surgery that provides an alternative to stoma pouches.
BiotechHardwareHealthtechMedical DevicesKfar Saba, IL
Boaz Assaf(CEO)in
PartnerAvi Fischer· solo GP
Co-investorsTriventures
Elicio Therapeutics is a biopharmaceutical company focused on developing therapeutic treatments.
BiotechHealthtech
PartnerAvi Fischer· solo GP
FDNA develops AI-powered diagnosis and care management tools that help parents, clinicians, and researchers identify developmental delays and rare genetic disorders early.
AI & Machine LearningDigital HealthHealthtechMedical DevicesBoston, US
Moti ShnibergProfessor Lior WolfErik Feingold(Co-Founder and CEO)in
PartnerAvi Fischer· solo GP
BiotechCambridge, US
Richard Gaynor, M.D.(Executive Officer)inRobert Ang, M.D.(Executive Officer)Yasir Al-Wakeel(Executive Officer)inEric Lander(Director)Hugh Dowd(Executive Officer, Director)
BoardCary Pfeffer, M.D.(Director)
Co-investorsNextech InvestSofinnova VenturesThird Rock Ventures
Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification.
HardwareHealthtechMedical Devices
Erez Golan(Founder)in
PartnerAvi Fischer· solo GP
Co-investorsAccelmed PartnersIndaco Venture PartnersSofinnova Partners
Sight develops immune signatures by analyzing live immune cells using AI to generate clinical insights.
AI & Machine LearningBiotechDigital Health
Ben Leshem(Chief Technology Officer)Nitsan Maayan-Rabinowich(Chief Executive Officer)Asi Cohen-Dotan(Chief Product & Clinical Officer)
PartnerAvi Fischer· solo GP
Co-investorsEmery CapitalGEOC
Constellation Pharmaceuticals was a Cambridge, MA clinical-stage biopharmaceutical company developing epigenetics-based cancer therapies, including BET and EZH2 inhibitors.
BiotechHealthtech
PartnerAvi Fischer· solo GP
Co-investorsExSight VenturesLongitude CapitalTachyon VenturesThe Column Group
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 2
1 IPOs · 1 acquisitionsMediwoundNASDAQ: MDWDThumbnail for Constellation Pharmaceuticalsacq. by Morphosys
Portfolio news
latest coverage across their companies
Elicio · stocktitan.net · Aug 13, 2026
Frequently asked questions
- How many investments has Clal Biotechnology Industries made?
- Clal Biotechnology Industries has 10 tracked investments, 2 of which have exited.
- What stage does Clal Biotechnology Industries invest at?
- Clal Biotechnology Industries invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Clal Biotechnology Industries focus on?
- Clal Biotechnology Industries focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Clal Biotechnology Industries located?
- Clal Biotechnology Industries is headquartered in Tel Aviv, IL.
- Who does Clal Biotechnology Industries co-invest with?
- Clal Biotechnology Industries most often shares deals with Indaco Venture Partners, Longitude Capital, New Era Capital Partners, among 14 tracked co-investors.
Images
Similar investors
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Bay City Capital is a venture capital firm founded in 1997 that has raised five venture funds totaling $1.3 billion in capital commitments and invested in more than 100 companies worldwide.
Gilde Healthcare is a specialist investment firm managing healthcare and climate-focused funds across venture & growth, and private equity strategies with a transatlantic team of sector specialists.
TVM Capital Life Science is a venture capital firm that invests in life science innovations, funding breakthrough therapies and medical products across biopharma, medtech, diagnostics, and digital health.





















